We found that the methylation levels of two discrete CpG sites (−365 and +360 bp) in FOXO3a promoter were significantly increased in breast cancer tissues compared with that in the normal tissues (Fig. 1e and Fig. S1A). This evidence concerns the gene FOXO3 and breast carcinoma.